TRVI - CIK 0001563880
Trevi Therapeutics, Inc. has filed 524 documents with the SEC between 2012 and 2026. The most frequent type is insider trade (192 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Annual report | 10-K | 2024-03-20 | 2023-12-31 |
| Major company event | 8-K | 2024-03-20 | 2024-03-20 |
| Insider trade | 4 | 2024-02-16 | 2024-02-15 |
| Insider trade | 4 | 2024-02-16 | 2024-02-15 |
| Insider trade | 4 | 2024-02-16 | 2024-02-15 |
| Insider trade | 4 | 2024-02-16 | 2024-02-15 |
| Insider trade | 4 | 2024-02-16 | 2024-02-15 |
| Insider trade | 4 | 2024-02-16 | 2024-02-15 |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-12 | - |
| Quarterly report | 10-Q | 2023-11-09 | 2023-09-30 |
| Major company event | 8-K | 2023-11-09 | 2023-11-09 |
| Insider trade | 4 | 2023-10-12 | 2023-10-11 |
| Insider trade | 4 | 2023-09-13 | 2023-09-11 |
| Insider sale notice | 144 | 2023-09-11 | - |
| EFFECT | - | 2023-08-15 | - |
| Insider trade | 4 | 2023-08-14 | 2023-08-11 |
| Company correspondence | CORRESP | 2023-08-14 | - |
| S-3/A | - | 2023-08-11 | - |
| Quarterly report | 10-Q | 2023-08-10 | 2023-06-30 |
| Major company event | 8-K | 2023-08-10 | 2023-08-10 |
| Insider trade | 4 | 2023-07-12 | 2023-07-11 |
| SEC correspondence | UPLOAD | 2023-07-05 | - |
| Insider trade | 4 | 2023-06-30 | 2023-06-28 |
| Insider trade | 4 | 2023-06-30 | 2023-06-28 |
| Insider trade | 4 | 2023-06-30 | 2023-06-28 |
| Insider trade | 4 | 2023-06-30 | 2023-06-28 |
| Insider trade | 4 | 2023-06-30 | 2023-06-28 |
| Insider trade | 4 | 2023-06-30 | 2023-06-28 |
| Securities registration | S-3 | 2023-06-29 | - |
| Major company event | 8-K | 2023-06-29 | 2023-06-28 |
| Insider trade | 4 | 2023-06-21 | 2023-06-20 |
| Insider trade | 4 | 2023-06-14 | 2023-06-12 |
| Insider sale notice | 144 | 2023-06-12 | - |
| Insider trade | 4 | 2023-05-15 | 2023-05-11 |
| Employee stock plan | S-8 | 2023-05-11 | - |
| Quarterly report | 10-Q | 2023-05-11 | 2023-03-31 |
| Major company event | 8-K | 2023-05-11 | 2023-05-11 |
| Annual report to shareholders | ARS | 2023-05-01 | 2022-12-31 |
| Proxy materials | DEFA14A | 2023-05-01 | - |
| Proxy statement | DEF 14A | 2023-05-01 | 2023-06-28 |
| PRE 14A | - | 2023-04-14 | 2023-06-28 |
| Major company event | 8-K | 2023-04-14 | 2023-04-13 |
| Insider trade | 4 | 2023-04-12 | 2023-04-11 |
| Insider sale notice | 144 | 2023-04-11 | - |
| Annual report | 10-K | 2023-03-16 | 2022-12-31 |
| Major company event | 8-K | 2023-03-16 | 2023-03-16 |
| Insider trade | 4 | 2023-03-15 | 2023-03-13 |